Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serological Tests in the Detection of SARS-CoV-2 Antibodies.
Guevara-Hoyer K, Fuentes-Antrás J, De la Fuente-Muñoz E, Rodríguez de la Peña A, Viñuela M, Cabello-Clotet N, Estrada V, Culebras E, Delgado-Iribarren A, Martínez-Novillo M, Torrejón MJ, Pérez de Diego R, Fernández-Arquero M, Ocaña A, Pérez-Segura P, Sánchez-Ramón S. Guevara-Hoyer K, et al. Diagnostics (Basel). 2021 Apr 9;11(4):678. doi: 10.3390/diagnostics11040678. Diagnostics (Basel). 2021. PMID: 33918840 Free PMC article.
Genomic crossroads between non-Hodgkin's lymphoma and common variable immunodeficiency.
Guevara-Hoyer K, Fuentes-Antrás J, de la Fuente-Muñoz E, Fernández-Arquero M, Solano F, Pérez-Segura P, Neves E, Ocaña A, Pérez de Diego R, Sánchez-Ramón S. Guevara-Hoyer K, et al. Among authors: fuentes antras j. Front Immunol. 2022 Aug 5;13:937872. doi: 10.3389/fimmu.2022.937872. eCollection 2022. Front Immunol. 2022. PMID: 35990641 Free PMC article.
Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors.
Fuentes-Antrás J, Martínez-Rodríguez A, Guevara-Hoyer K, López-Cade I, Lorca V, Pascual A, de Luna A, Ramírez-Ruda C, Swindell J, Flores P, Lluch A, Cescon DW, Pérez-Segura P, Ocaña A, Jones F, Moreno F, García-Barberán V, García-Sáenz JÁ. Fuentes-Antrás J, et al. Int J Mol Sci. 2023 Jul 13;24(14):11419. doi: 10.3390/ijms241411419. Int J Mol Sci. 2023. PMID: 37511178 Free PMC article.
Hyperprogression as a distinct outcome after immunotherapy.
Fuentes-Antrás J, Provencio M, Díaz-Rubio E. Fuentes-Antrás J, et al. Cancer Treat Rev. 2018 Nov;70:16-21. doi: 10.1016/j.ctrv.2018.07.006. Epub 2018 Jul 18. Cancer Treat Rev. 2018. PMID: 30053725 Review.
29 results